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WAKE-PROMOTING EFFECTS OF GLUTAMATERGIC 
PEDUNCULOPONTINE TEGMENTAL NEURONS 
CAROLYN GERACI 
ABSTRACT 
The pedunculopontine tegmental (PPT) nucleus is a brainstem structure thought to 
be important in the regulation of sleep/wake states. The PPT is comprised of three 
distinct types of neurons (cholinergic, GABAergic, and glutamatergic), and each may 
serve different functions. It remains unknown how PPT neurons affect specific 
sleep/wake states and which of their axonal projections mediate their effect. Therefore, 
we used optogenetics to selectively activate glutamatergic PPT (PPTglut) neurons at both 
the cell soma and axon terminals in a temporally and spatially precise manner. 
The purpose of these experiments was to determine the role of PPTglut neurons 
during wake, non-rapid eye movement (NREM) sleep, and rapid eye movement (REM) 
sleep, and to identify the key projections through which PPTglut neurons produce their 
effects.  
Using transgenic mice, we transfected PPTglut neurons with an adeno-associated 
viral vector to induce expression of a light-dependent ion channel, channelrhodopsin-2 
(ChR2). While recording electroencephalography (EEG), electromyography (EMG), and 
video feed, we photostimulated the transfected PPTglut neurons and measured the effects 
on sleep/wake states of the mice. 
Stimulation of the PPTglut soma during NREM sleep produced a frequency-
dependent wake response. With increasing frequency of stimulation, we observed an 
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increase in the speed of the wake response, as well as the amplitude and duration of the 
wake response. Stimulating the PPTglut soma increased time spent in wake, decreased 
NREM sleep, and slightly decreased REM sleep. We also noticed that mice did not 
exhibit spontaneous body movements during stimulation of the PPTglut soma. 
Stimulating individual PPTglut axon terminal fields partially recapitulated the 
phenotype observed with stimulation of the cell soma. Photostimulation of axon terminals 
in the basal forebrain, lateral hypothalamus, and thalamus elicited a fast wake response, 
stimulation of both the basal forebrain and lateral hypothalamus terminal fields produced 
a strong wake response, but long-lasting wakefulness was observed only with high-
frequency stimulation of axon terminals in the lateral hypothalamus.  
In summary, photostimulation of PPTglut neurons promotes wake, and slightly 
decreases REM sleep. Our experiments strongly support the role of PPTglut neurons in 
promoting wakefulness from NREM sleep, and this wake response is carried out through 
several axonal projections which, in sum, recapitulate the wake phenotype observed with 
stimulation of the cell soma in the PPT itself. Further exploration of the axonal 
projections of PPTglut neurons is warranted to elucidate the neuronal targets through 
which this response is carried out. 
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INTRODUCTION 
 Chronic sleep disorders affect an estimated 50 to 70 million Americans (Institute 
of Medicine (US) Committee on Sleep Medicine and Research, 2006). Sleep disorders 
can have wide-reaching consequences throughout all aspects of a patient’s life, putting 
them at increased risk for heart attack, stroke, depression, substance abuse, and 
neurodegenerative diseases (Institute of Medicine (US) Committee on Sleep Medicine 
and Research, 2006). Disrupted sleep and sleep deprivation contribute to drowsy driving, 
endangering even unaffected people (Klauer et al., 2006). To better understand 
disordered sleep, we must first understand the underlying circuitry that controls sleep 
states. In this project, we investigated the pedunculopontine tegmental (PPT) nucleus, a 
brainstem structure that contributes to wakefulness. 
 There are three general vigilance states: wake, rapid eye movement (REM) sleep, 
and non-REM (NREM) sleep. REM sleep is so named because rapid eye movements 
occur during this stage of sleep in humans (McCarley, 2007). Electroencephalogram 
(EEG) signals during REM sleep in mice tend to be high in amplitude, at a frequency of 
6-9 Hz (called ‘theta power’). Another characteristic of REM sleep is ‘REM sleep 
paralysis’, a lack of muscle tone during this sleep stage, detectable as an absence of 
signal on the Electromyogram (EMG). NREM sleep is characterized by high-amplitude 
activity in the delta power range (0.5-4 Hz) (McCarley, 2007). Wake is associated with a 
more variable EEG and EMG signal, usually with low-amplitude, high-frequency EEG 
components.  
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Historically, the brainstem has been considered essential for wakefulness. 
Through observation of clinical lesions in human patients in the early 20th century, 
scientists proposed the idea of an arousal system originating in the brainstem and 
projecting to the forebrain. When activated, this brainstem arousal system would send 
ascending signals to the forebrain, keeping a person awake (Saper et al., 2005). Further 
supporting this theory, when scientists directly stimulated the brainstem ‘reticular 
formation’ in anesthetized cats, the EEG signals matched that of a natural arousal from 
sleep (Moruzzi and Magoun, 1949). In addition, studies using transections just above the 
pons in cats produced persistent drowsiness (Bremmer, 1935), reviewed in (Schwartz and 
Kilduff, 2015). 
Several nuclei lie within the brainstem reticular formation, including the 
pedunculopontine tegmental (PPT) nucleus and the laterodorsal tegmental (LDT) 
nucleus, both of which project to the thalamus and provide important contributions to the 
arousal response (Krout et al., 2002). The PPT has ascending projections to many brain 
areas, including the lateral hypothalamus, thalamus, septal nuclei, amygdala, globus 
pallidus, and substantia nigra (Hallanger and Wainer, 1988; Saper and Loewy, 1982). It is 
delineated by a cluster of cholinergic neurons in the brainstem (Armstrong et al., 1983), 
and comprised of intermingled populations of cholinergic, GABAergic, and 
glutamatergic neurons (Wang and Morales, 2009). Depending on which anatomical 
region of the PPT they originate from, neurons of the same phenotype may have varying 
projections and densities (Martinez-Gonzalez et al., 2011).  
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The role of the PPT in sleep has been examined using a number of different 
methods. Electrical stimulation of the PPT region produces a wake-like EEG (Steriade et 
al., 1990), and chronic low-amplitude stimulation of the nearby LDT increases REM 
sleep (Thakkar et al., 1996). Furthermore, discharge profiles demonstrate that 
cholinergic, GABAergic, and glutamatergic PPT neurons all fire in association with wake 
and REM sleep to varying extents (Boucetta et al., 2014; Datta and Siwek, 2002). 
Multiple studies of pontine lesions support the idea that pontine lesions can decrease 
REM sleep (Carroll and Landau, 2014). This could be mediated by loss of cholinergic 
PPT neurons, as some studies show that lesioning the cholinergic PPT reduces REM 
sleep (Webster and Jones, 1988). However, others suggest that pontine cholinergic inputs 
are not required for REM sleep generation (Grace et al., 2014; Grace and Horner, 2015). 
In fact, a separate lesion study found that lesions to the cholinergic PPT did not 
significantly change sleep architecture (Deurveilher and Hennevin, 2001). Optogenetics 
allows one to stimulate specific axon terminals, which is not possible with electrical or 
chemogenetic methods. Previous experiments using optogenetics have examined only the 
cholinergic PPT neurons. In one study, cholinergic PPT stimulation increased transitions 
into REM sleep in mice (Van Dort et al., 2015).  
In humans, electrical stimulation of all cell types in the PPT also affects 
sleep/wake states. Low frequency deep brain stimulation (DBS) of the PPT region in 
patients with Parkinson’s disease produced alertness, while sudden withdrawal of low-
frequency stimulations induced REM sleep. Conversely, high-frequency stimulation 
induced NREM sleep (Arnulf et al., 2010). This increase in NREM sleep could be due to 
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a depolarization block, a lack of neuron firing that occurs with sustained high-frequency 
stimulation. 
Recent experiments have focused on defining the roles of the three different 
neuron types that comprise the PPT. Using new genetic tools, researchers can selectively 
activate glutamatergic, GABAergic, and cholinergic neurons of the PPT. One such tool is 
‘chemogenetics’, which uses a genetic approach to selectively express a modified 
muscarinic receptor in specific cells, which can then be activated with a drug (Clozapine-
N-oxide) designed to exclusively activate those receptors. Using chemogenetics, 
researchers have shown that selective activation of glutamatergic PPT neurons produces 
wakefulness, activation of cholinergic neurons suppresses NREM sleep, and activation of 
GABAergic neurons slightly reduces REM sleep (Kroeger et al., 2017).  
We chose to examine PPTglut neurons because previous chemogenetic 
experiments have suggested a significant arousal phenotype which requires detailed 
characterization (Kroeger et al., 2017). We used a method called optogenetics, which is 
similar to chemogenetics in its genetic selectivity, but permits activation of neurons on a 
millisecond time-scale using laser light directed into the brain (Boyden et al., 2005). 
Previous methods of stimulation have lacked either temporal or genetic precision; 
Electrical stimulation indiscriminately activates all cell types in the region, and 
chemogenetic methods do not allow for temporally precise stimulation.  
In the following experiments, we hypothesized that photostimulation of the 
glutamatergic PPT in mice would produce wake via axonal projections to the basal 
forebrain, interrupt NREM sleep, and have little effect on REM sleep. To test this 
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hypothesis, we used optogenetics to specifically activate PPTglut neurons and their axonal 
projections while mice were in NREM sleep, REM sleep, or wake and measured changes 
in their sleep states.  
 
  
 6 
 
METHODS 
Optogenetics and Study Design 
 To selectively only glutamatergic neurons in an otherwise heterogeneous cluster 
of cells (Bevan and Bolam, 1995; Ford et al., 1995; Mena-Segovia et al., 2009; Wang and 
Morales, 2009), we used a ‘cre-lox’ recombination system with optogenetics. The general 
theory behind this design is to use a genetically modified mouse line which expresses cre 
recombinase only in glutamatergic neurons, and to transfect these neurons with a virus to 
selectively induce expression of a cre-dependent, light-responsive ion channel. This 
manipulation allows one to selectively target and activate only glutamatergic neurons of 
the PPT by shining blue light through an optical fiber implanted in the brain. 
 Specifically, we employed the ‘cre-lox’ recombination system in transgenic mice 
expressing cre-recombinase (cre) driven by the promoter for vesicular glutamate 
transporter 2 (vGluT2) – ‘vGluT2-Cre mice’. Cre is an enzyme that recombines DNA at 
target sequences called LoxP sites (Nagy, 2000). Using an adeno-associated virus (AAV) 
delivery system, we inserted the genetic material for the light-sensitive ion channel 
Channelrhodopsin-2 (ChR2) into neurons in the PPT region. However, the delivered 
genetic sequence is by design coded in reverse, preventing gene expression. In neurons 
expressing cre, the enzyme identifies the flanking LoxP sites and flips the ChR2 gene to 
permit transcription (Madisen et al., 2012; Zeng and Madisen, 2012). Since, in these 
mice, cre is present only in neurons producing vGluT2, only glutamatergic neurons can 
express ChR2 (Figure 1). 
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Figure 1: Cre-dependency of ChR2 and fluorophore expression using a double-
floxed inverse open reading frame (DIO) strategy. In neurons that express cre, the 
ChR2 and fluorescent mCherry genes are flipped by the cre enzyme and are therefore 
able to be transcribed. ITR = inverted terminal repeats. EF1a = promotor. mCherry = 
flourophore. ChR2 = channelrhodopsin-2. WPRE = woodchuck hepatitis virus post-
transcriptional regulatory element. hGH polyA = human growth hormone 
polyadenylation signal (adapted from Smedemark-Margulies and Trapani, 2013). 
 
 ChR2 is an opsin that creates a net positive inflow of ions into a neuron when 
activated with light between 420-510 nm (Bamann et al., 2008; Zhang et al., 2007). To 
insert this gene into PPT neurons, we bilaterally injected a viral vector 
(AAV8:EF1a:DIO:ChR2:mCherry), ‘AAV-ChR2’, into the PPT area of vGluT2-cre 
mice. The transfected glutamatergic neurons were able to transcribe ChR2, which 
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integrates into the cell membrane throughout the cell soma and the axon terminals. ChR2 
was tagged with the fluorescent marker mCherry, which we later mapped using 
fluorescent microscopy to assess the extent of our viral transfection. 
After two weeks of recovery, we connected the optical fibers to a laser source 
emitting blue light at 473 nm to activate the PPTglut neurons. 
Animal Care 
 For these experiments, we used transgenic vGlut2-Cre mice backcrossed to 
C57BL/6J for more than 6 generations from Jackson Laboratory (stock #016963). All 
mice were males between 8-10 weeks of age at the time of surgery, weighing between 
25-30 g. Prior to surgery, mice were group-housed in a barrier animal facility. After 
surgery, mice recovered single-housed in the barrier facility, then were transferred to 
single-housed cages in our satellite facility. Cages included food and water ad libitum and 
nesting material for enrichment. Mice were on a 12:12 light/dark cycle, with lights on at 
5:00 AM. Our satellite room was kept at 22 +/- 1.6 degrees Celsius, and 25 +/- 2.2 mmHg 
humidity. All animal care protocols were in accordance with the National Institutes of 
Health Guidelines and approved by the Institutional Animal Care and Use Committee of 
Beth Israel Deaconess Medical Center.  
Surgeries 
  When mice were between 8-10 weeks of age, we injected AAV-ChR2 to induce 
ChR2 and mCherry expression in the PPT, placed an optical fiber into either the PPT or 
one of four PPT axon terminal fields, and implanted EEG and EMG recording leads.  
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 For these surgical interventions, we anesthetized animals with an intraperitoneal 
injection of ketamine/xylazine at 100/10 mg/kg. Mice were fixed into a stereotaxic frame, 
and we began by injecting the AAV bilaterally. All mice received viral injections into the 
PPT, but 9 mice were implanted with optical fibers to stimulate cell soma (Figure 2A), 
while 4 mice received optical fibers in the basal forebrain, 1 mouse in the lateral 
hypothalamus, 1 mouse in the thalamus, and 2 mice in the substantia nigra (Figure 2B). 
Finally, we placed EMG recording electrodes in the neck muscles, and EEG recording 
electrodes on the skull. Injection and fiber coordinates were determined using a mouse 
brain atlas (Paxinos and Franklin, 2004). 
 
 
Figure 2: Optical fiber placement. A) Fibers were placed at the PPT soma for cell body 
stimulations. B) Optical fibers were placed at one of four candidate axonal projection 
sites for axon terminal stimulations. Red = basal forebrain. Yellow = medial thalamus. 
Green = lateral hypothalamus. Blue = substantia nigra. 
 
After surgery, mice were placed on heating pads to prevent post-operative 
hypothermia, and given sub-cutaneous meloxicam (5 mg/kg) for pain management. 
Animals recovered for two weeks single-housed in the barrier facility, then were 
transported to our recording cages in the satellite facility. After 1-2 days of acclimation to 
A)                 B) 
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their new environment, we attached their EEG/EMG leads to recording cables and also 
attached optical patch cords to the implanted optical fibers for light delivery.  
Data Acquisition 
 We used sleep recording software (Vital Recorder, Kissei Comtec) to record 
EMG, EEG, video, and laser stimulation signals from our mice. All mice underwent 
several stimulation protocols with rest days in-between: 
Stimulation Protocol 1: Stimulations of varying frequencies during NREM sleep 
Stimulation was initiated by an experimenter activating a 10-second-long laser 
stimulation after a mouse had been in NREM sleep for 30 seconds. We performed 16 
trials at each of six laser frequencies: 0.5 Hz, 1 Hz, 5 Hz, 10 Hz, 20 Hz, and sham 
stimulation. To control for order effects, the progression through stimulation frequencies 
was randomized. Sham stimulations involved inserting a timestamp on the recording 
when a mouse had been in NREM sleep for 30 seconds, but the laser was not activated. 
Stimulations were performed in the final 6 hours of the light period (between 11:00 AM 
and 5:00 PM). If a stimulation caused the mouse to wake, we allowed at least one 
complete natural cycle of sleep before resuming testing to prevent confounding effects 
from sleep deprivation.  
Stimulation Protocol 2: Stimulations randomly applied during any vigilance state  
The second stimulation protocol involved automated, randomized stimulation 
under three different conditions: stimulation applied bilaterally, unilaterally (only one 
hemisphere was stimulated), and sham stimulation (control condition). For this protocol, 
sham stimulations were timestamped, but the laser was turned off. Unilateral stimulation 
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was accomplished by randomly turning off one of the two lasers. Mice received 5 Hz 
stimulations 8 times per hour at random intervals for 48 hours, beginning at the start of 
the dark period (5:00 PM). We chose this stimulation frequency based on pilot studies 
showing that 5 Hz stimulation of the PPTglut soma was the lowest physiological 
frequency that reliably woke mice from NREM sleep. 
Stimulation Protocol 3: Prolonged automated stimulation during any vigilance state  
We also performed a five-minute-long stimulation at 5 Hz, intended to investigate 
the lack of movement observed during stimulation of PPTglut cell bodies. We set this 
automated 5 Hz, 5-minute stimulation to occur at random intervals twice per hour for 24 
hours, beginning at the start of the dark period (5:00 PM).  
Data Analysis 
 We scored all recordings using SleepSign software (Kissei Comtec), integrating 
the EEG, EMG, and video recording signals to assign a sleep state to epochs 
encompassing either 5 or 10 seconds.  
Sleep Scoring: Protocol 1 
To assess the frequency-dependent wake response during NREM sleep, we scored 
recordings from the first stimulation protocol in 5-second epochs, using a “percent 
wakefulness” scale, the criteria of which are detailed in Table 1. The person scoring was 
blinded to the frequency of the laser stimulation. To objectively quantify the wake 
response, we performed a Fast Fourier transform (FFT) analysis of the same recordings in 
10-second epochs, analyzing EEG frequencies in the delta range (between 0.5 Hz and 4 
Hz).  
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Table 1: “Percent wakefulness” scoring system. EEG/EMG signals were categorized 
according to the following characteristics. 
 
Percent  
wakefulness score 
Characteristics 
 
0% 
EMG: no activity 
EEG: high-amplitude, low-frequency waves 
 
25% 
EEG: some low-amplitude waves 
EMG: very little/no activity (or) 
EEG: normal NREM sleep activity 
EMG: some minor activation 
 
50% 
EEG: some reduced-amplitude, increased-frequency waves  
EMG: some activity (or) 
EEG: some high-amplitude activity (when falling back to sleep) 
EMG: inactive 
 
 
 
75% 
EEG: normal sleep activity 
EMG: strong burst, surrounded by normal EEG/EMG sleep 
activity (or) 
EEG: low-amplitude, high-frequency 
EMG: no activity, mouse beginning to fall back to sleep (or) 
EEG: suppressed during stimulation, preceding post-stimulation 
EMG activity 
 
100% 
EEG: low-amplitude, high-frequency 
EMG: strong signal (or) 
EEG: wakefulness induced by laser stimulation 
EMG: activated following termination of laser pulse 
 
Sleep Scoring: Protocol 2 
We used the recordings from the second protocol (stimulation, sham-stimulation, 
and unilateral stimulation) for a number of different analyses. For all recordings, we 
scored sleep/wake states for one minute before and one minute after each stimulation for 
the entire first light period of the 48-hour recording, assigning each 10-second epoch a 
sleep state: NREM sleep, REM sleep, or wake. We used this data to produce graphs of 
sleep architecture immediately before and after stimulation.  
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Moreover, we analyzed the first 15 instances of a stimulation occurring after at 
least one epoch of NREM sleep. Looking at these stimulation events that randomly 
occurred during NREM sleep, we calculated the duration of NREM sleep bouts by 
measuring the length of time spent in NREM sleep before a state transition occurred. In 
contrast, we calculated the latency to wake not from the beginning of the NREM sleep 
bout, but from the beginning of the 10-second stimulation until the animal woke, 
regardless of whether this occurred during or after the end of stimulation. We performed 
these analyses for NREM sleep as well as for REM sleep. 
Sleep Scoring: Protocol 3 
To investigate whether or not mice initiated movements during the 
photostimulation period, we analyzed the recordings with 5-minute-long stimulation at 5 
Hz. We calculated the latency to movement as the period from the start of the stimulation 
until the first ‘significant movement’. ‘Significant movement’ was defined as a strong 
EMG signal lasting more than 0.5 seconds, combined with clear movement of the trunk, 
head, or neck on the video recording.  
Immunohistochemistry 
Perfusion 
 After all experimental recordings were completed, mice were sacrificed under 
deep anesthesia with ketamine/xylazine (150/15 mg/kg, injected intraperitoneally). We 
intracardially perfused them with phosphate buffered saline (PBS) to wash blood out of 
the cardiovascular system, followed by 10% formalin to fix the tissue. The brains were 
removed and stored in 10% formalin for 24-48 hours post-perfusion, then we transferred 
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them into a cryoprotective solution (30% sucrose in PBS) for at least 24 hours before 
sectioning. 
Sectioning 
 Frozen brains were sectioned into three series using a microtome at 30 µm, then 
stored in PBS-azide (azide prevents microbial growth).  
Staining for injection site and optical fiber placement validation 
 Sections were stained with both 3,3’ Diaminobenzadine (DAB) and fluorescent 
stains to visualize the locations of our optical fibers and the location and extent of our 
viral transfection. 
 The first step of the DAB stain labelled cfos in black, to identify recently active 
cells (Joo et al., 2016). Tissue was incubated with a rabbit anti-cfos primary antibody 
(Millipore, product #ABE457, lot #2672548), then amplified with a donkey anti-rabbit 
secondary antibody (Jackson Immunoresearch, product #711065152, lot #122049) and an 
avidin-biotin complex. Immunoreactive cells were then stained with DAB and nickel, 
which labelled nuclei containing cfos in black.  
The second round of DAB staining labelled virally transfected PPT neurons 
expressing mCherry and ChR2. We began with a rabbit anti-dsRed primary antibody 
(Clontech, product #632496, lot #1612022), then amplified the signal with a donkey anti-
rabbit secondary antibody (Jackson Immunoresearch, product #711065152, lot #122049) 
and an avidin-biotin complex. This DAB stain did not contain nickel, and resulted in a 
brown labeling of virally transfected PPT neurons.  
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In another series of brain sections, we used fluorescent immunohistochemistry to 
visualize the extent of our viral transfection in the context of the PPT. Since the PPT is 
defined by a region of cholinergic neurons (Armstrong et al., 1983), we used a primary 
antibody against choline acetyltransferase (ChAT), an enzyme found at high levels in 
cholinergic neurons. The primary antibody was a goat anti-ChAT antibody (Millipore, 
product #AB144P), which we amplified with a donkey anti-goat secondary antibody 
(Jackson Immunoresearch, product #705065147, lot #126488). Immunopositive cells 
were visualized by labelling with an anti-donkey streptavidin, Alexa 488 (Invitrogen, 
product #S11223, lot #55929A). This reaction marked cholinergic PPT neurons in green.  
Using fluorescent microscopes, we visualized the red fluorescence of the mCherry tag 
(which PPTglut neurons expressed due to viral transfection) as well as the green 
fluorescence of the cholinergic PPT neurons, allowing us to evaluate whether virally 
transfected neurons were indeed located within the PPT region. 
We mounted all stained sections on glass slides for imaging on a slide-scanning 
microscope (see Kroeger, et. al. 2017 for details). We used OlyVia software (Olympus 
Life Sciences) to scan these slides into a digital format and later employed GNU Image 
Manipulation Program (GIMP) to map viral injection sites and optical fiber placements. 
Visualization of axonal connections using confocal microscopy 
For a limited number of brains, we performed an additional fluorescent stain to 
visualize the axonal connections of PPTglut projections within the terminal fields. We 
used a confocal microscope to examine if appositions were present on neurons in the 
PPTglut terminal fields. 
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  We chose sections representing the terminal fields of interest and stained each 
using a rat anti-mCherry antibody (Life Technologies, product #M11217, lot 
#QE214609), then a donkey anti-rat secondary antibody with an attached fluorophore, 
Alexa 594 (Invitrogen, product #21209, lot #1744721). This amplified the fluorescent 
marker mCherry, revealing more robustly the axons and terminals of PPTglut neurons in 
red. After this step, sections from each terminal field were stained separately: 
 Sections of the basal forebrain were stained for cholinergic neurons using a goat 
anti-ChAT primary antibody (Millipore, product #AB1448, lot #2929343), followed by a 
donkey anti-goat secondary antibody (Jackson, product #705065147, lot #126488) and a 
streptavidin green fluorophore, Alexa 488 (Immunogen, product #S11223, lot #55929A). 
 In the lateral hypothalamus, orexin neurons were stained using a goat anti-Orexin 
A primary antibody (Santa Cruz, product #SC8070, lot #CO512), followed by a donkey 
anti-goat secondary antibody (Jackson, product #705065147, lot #126488) and Alexa 488 
(Immunogen, product #S11223, lot #55929A). Sections of the lateral hypothalamus were 
also stained for melanin-concentrating hormone (MCH) neurons using a rabbit anti-MCH 
primary antibody, followed by a donkey anti-rabbit secondary antibody (Jackson, product 
#705065147, lot #126488) and Alexa 488 (Immunogen, product #S11223, lot #55929A). 
 In the substantia nigra, dopaminergic neurons were stained using a rabbit anti-
tyrosine hydroxylase primary antibody (Millipore, product #AB152, lot #2695213), 
followed by a donkey anti-rabbit secondary antibody (Jackson, product #711065152) and 
Alexa 488 (Immunogen, product #S11223, lot #55929A). 
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 To coverslip our slides, we used a sealant containing 4’,6-diamidino-2-
phenylindole (DAPI), a fluorescent stain that binds to DNA, labelling cell nuclei in blue. 
Statistical Analysis 
 As this is an ongoing project, some data for the stimulation of PPTglut axons at the 
terminal fields is still preliminary. Where cohort numbers exceeded 1 mouse, we 
performed a two-tailed, type 1 student’s t-test with a significance level of p < 0.05. The 
error bars in the graphical representations of our results indicate the standard error of the 
mean.  
Exclusion criteria 
 Viral injection sites were mapped against the location of ChAT-positive cells, 
which define the borders of the PPT. If more than 25% of the virally transfected neurons 
were outside of the borders of the PPT, the mouse was excluded from analysis. Mice 
were also excluded if the EEG or EMG signals were not clear or displayed major 
interference. 
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RESULTS 
Injection and optical fiber site mapping 
 Before analyzing data from any of our experimental mice, we stained brain 
sections from each mouse to histologically confirm injection site placements. We used 
fluorescent staining to assess viral transfection of the PPTglut neurons, and DAB staining 
to confirm correct placement of the optical fibers (Figure 3). 
 
Figure 3: Microscope images of injection and optical fiber sites. This is a coronal 
section at the level of the PPT. The left side is a DAB stained section, where brown stain 
labels neurons transfected by our AAV, expressing ChR2 and mCherry. The right side is 
a fluorescently stained section, where the green stain labels cholinergic neurons, and the 
red stain labels neurons transfected by our virus. The optical fiber sites can be seen 
bilaterally, with their tips ending just above the PPT region.  
 
 Figure 4 shows the extent of our injections and optical fiber placements.   
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Figure 4: Schematic of injection and optical fiber sites. A) Overlapping grey areas 
indicate mCherry expression in the PPT of each mouse. B) Optical fiber placement in the 
PPT. Lines indicate the tip of optical fibers. C) PPT injection sites for the mice 
stimulated at the basal forebrain terminal field. n = 4. D) Fiber sites in the basal forebrain. 
E) PPT injection site for the mouse stimulated at the lateral hypothalamus terminal field. 
n = 1. (Tissue quality has made optical fiber mapping difficult for this mouse, and fiber 
sites have been omitted here). F) PPT injection site for the mouse stimulated at the 
thalamus terminal field.  n = 1. G) Fiber sites in the thalamus. H) PPT injection sites for 
the mice stimulated at the substantia nigra terminal field.  n = 2. I) Fiber sites in the 
substantia nigra. Coordinates indicated are relative to bregma. 
 
Stimulation of the PPTglut soma 
Frequency-dependent wake response during NREM sleep 
Prior to my arrival in the lab, Dr. Daniel Kroeger and another student, Jack 
Thundercliffe, had completed the recordings and partial analysis of optogenetic 
manipulations at the soma of PPTglut neurons. They stimulated at various frequencies 
while animals were in NREM sleep (stimulation protocol 1). We scored percent 
wakefulness in five-second epochs before, during, and after the ten-second stimulation. 
Stimulation during NREM sleep caused a frequency-dependent wake response (Figure 
5). The wake response was strong, occurred rapidly after stimulation onset, and 
wakefulness was sustained even after withdrawal of stimulation.   
I) 
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Figure 5. Frequency-dependent wake response to optogenetic stimulation of PPTglut 
soma during NREM sleep. Optogenetic activation of PPTglut soma during NREM sleep 
produced a rapid increase in percent wakefulness. Stimulation frequencies between 0.5-
20 Hz produced a strong wake response, and stimulations with frequencies above 10 Hz 
produced a sustained wake response. Grey bar represents the 10 s stimulation period. 
Data scored in 5 s epochs. n = 9 mice. 
 
The wake response was strongest with stimulation frequencies at 5 Hz and above. 
Stimulation at 20 Hz, the highest frequency tested, increased wakefulness to 97% in the 
epoch immediately following the end of stimulation. 10 Hz and 5 Hz stimulations caused 
a similar response, with wakefulness levels reaching 96% and 88%, respectively, after the 
end of stimulation. Lower frequency stimulations (0.5 Hz, 1 Hz) also caused an increase 
in percent wakefulness, but the magnitude of wakefulness was about half of that seen at 5 
Hz and above.  
The change in wakefulness happened rapidly after stimulation onset. Since our 
protocol required that animals were in NREM for at least 30 seconds before these 
0
10
20
30
40
50
60
70
80
90
100
-10 -5 Stim 1 Stim 2 5 10 15 20 25 30
Pe
rc
en
t w
ak
ef
ul
ne
ss
 
Time, relative to end of stimulation period (s)
Sham 0.5 Hz 1 Hz 5 Hz 10 Hz 20 Hz
 23 
 
stimulations, baseline levels of “percent wakefulness” were between 0% and 1%. During 
the two epochs that we stimulated, percent wakefulness rose quickly. In the first 
stimulation epoch, percent wakefulness rose to approximately 27% with 0.5 Hz, 32% 
with 1 Hz stimulations, 56% with 5 Hz, 66% with 10 Hz, and 67% with 20 Hz 
stimulations. 
The wake response was also sustained after the stimulation ended, most notably 
when we stimulated at 20 Hz. Mice stayed awake for as long as 30 seconds after 
stimulation. With 20 Hz stimulation, percent wakefulness remained at 76% at 30 seconds 
after the stimulation ended. 
To objectively quantify this wake response, we performed an FFT analysis to 
measure the delta power present in the EEG signal before, during, and after stimulation 
(Figure 6). Delta is the range of EEG frequencies from 0.5-4 Hz that is characteristicly 
elevated in EEG signals during NREM sleep in mice (McCarley, 2007). For comparison, 
we also analyzed average delta power during uninterrupted NREM sleep and 
uninterrupted wake for each animal (indicated by the dotted and solid horizontal lines, 
respectively). 
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Figure 6. FFT analysis of stimulation at PPTglut soma during NREM sleep. EEG 
delta power decreased after stimulation at the PPTglut soma. Stimulations at 5 Hz, 10 Hz 
and 20 Hz caused a rapid decrease in EEG delta power. Grey bar represents the 10 s 
stimulation period. Data scored in 10 s epochs. n = 9 mice.  
 
Since mice were in NREM sleep in the epoch immediately preceding stimulation, 
delta power was high. Stimulations at 5 Hz, 10 Hz, and 20 Hz caused delta power to 
immediately decrease, to a level near that of an awake mouse. 0.5 Hz and 1 Hz 
stimulations also caused a decrease in delta power, but to a lesser extent than the higher 
frequency stimulations. The decrease in delta power was sustained after the end of 
stimulation at all frequencies tested. Delta power did not return to baseline NREM sleep 
levels during the 30 seconds following any stimulation frequency. 
Sleep architecture 
We used a randomized stimulation protocol to investigate the effects of 
stimulation on sleep architecture (stimulation protocol 2). These occurred at random 
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intervals, irrespective of the vigilance state the mouse happened to be in prior to 
stimulation. We chose to stimulate at 5 Hz for this protocol because it was the lowest 
frequency that reliably produced a wake response in our previously described manual 
stimulation protocol (stimulation protocol 1). 
Figure 7 shows the percent of time animals spent in each vigilance state. For 
reference, control mice spent an average of 60% of this time in NREM sleep, 30% in 
wake, and 10% in REM sleep. During the 10-second stimulation, mice spent 93% of the 
time in a wake state, and almost no time in NREM sleep (1%). REM sleep was much less 
affected by activation of PPTglut soma, but there was a minor decrease in amount of time 
spent in REM sleep during and after stimulation. Mice spent an average 10% of time in 
REM sleep in the 60 seconds preceding stimulation, but an average of 4% of time in 
REM sleep in the 60 seconds during and after stimulation.  
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Figure 7. Sleep architecture with stimulation at the PPTglut soma. Sleep architecture 
was altered by optogenetic stimulation of PPTglut soma. Time spent in wake increased 
during and immediately following stimulation, with a corresponding decrease in time 
spent in NREM sleep. Percent of time spent in REM sleep slightly decreased with 
stimulation. Grey bar represents the 10 s of 5 Hz stimulation period. Data scored in 10 s 
epochs, taken from the first light period. n = 6 mice. 
 
Bout length and latency to wake 
Using the same recordings from our random stimulation protocol, we scored both 
sleep bout length and latency to wake after stimulation. When stimulations occurred 
during NREM sleep, NREM sleep bout lengths decreased significantly compared to sham 
stimulations (Figure 8A, p = 0.002). Mice woke up quickly if stimulations occurred 
during NREM sleep (Figure 8B, p = 0.002). 
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Figure 8. Bout length and latency to wake with stimulation of PPTglut soma during 
NREM sleep. Optogenetic stimulation of PPTglut soma during NREM sleep decreased A) 
NREM sleep bout length and B) latency to wake. 10 s stimulation at 5 Hz. Data taken 
from first 15 stimulations during the light period. n = 6 mice. ** p < 0.01 vs. sham. 
 
 REM sleep did not appear to be interrupted to the same extent as NREM sleep. 
When stimulations fell during REM sleep, REM sleep bout lengths did not change 
significantly (Figure 9A, p = 0.133). Latency to wake, however, was decreased slightly 
by stimulation (Figure 9B, p = 0.043).  
 
Figure 9. Bout length and latency to wake with stimulation of PPTglut soma during 
REM sleep. Optogenetic stimulation of PPTglut soma during REM sleep did not change 
A) REM sleep bout length, but reduced B) latency to wake. 10 s stimulation at 5 Hz. Data 
taken from the first 15 stimulations of the light period. n = 6 mice. *p < 0.05 vs. sham. 
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Bilateral vs. unilateral stimulation 
 
We also compared the effects of unilateral stimulation vs. bilateral stimulation of 
the PPTglut soma, using the same stimulation protocol. 
When unilateral stimulations occurred during NREM sleep, the NREM sleep bout 
length was not significantly different than bout length with bilateral stimulations (Figure 
10A, p = 0.983). Latency to wake was decreased with unilateral stimulations (Figure 
10B, p = 0.021). However, the absolute latency between these two conditions were very 
comparable. 
 
Figure 10. Bout length and latency to wake with bilateral and unilateral PPTglut cell 
body stimulation during NREM sleep. Unilateral and bilateral stimulations of the 
PPTglut soma had comparable effects on NREM sleep. A) NREM sleep bout length was 
not significantly different with unilateral stimulations, but B) latency to wake appeared to 
be slightly faster with unilateral stimulations. 10 s stimulation at 5 Hz. Data taken from 
the first 15 stimulations of the light period. n = 5 mice. *p < 0.05 vs. bilateral. 
 
If stimulations fell during REM sleep, neither REM sleep bout lengths (Figure 
11A, p = 0.735) nor latency to wake (Figure 11B, p = 0.261) differed significantly 
between bilateral or unilateral stimulations.  
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Figure 11. Bout length and latency to wake with bilateral and unilateral PPTglut cell 
body stimulation during REM sleep. Unilateral and bilateral stimulations of PPTglut cell 
bodies have comparable effects on REM sleep. Neither A) REM sleep bout length nor B) 
latency to wake differed significantly between the two conditions. 10 s stimulation at 5 
Hz. Data taken from the first 15 stimulations of the light period. n = 5 mice. 
 
 
Optogenetic stimulation of terminal fields of PPTglut neurons 
Selecting target sites for stimulation of axonal terminals of PPTglut neurons 
 
After examining the effects of stimulation of the PPTglut soma, we investigated the 
contributions of different axonal projections to our observed wake response. We selected 
four different terminal fields of PPTglut axons. 
  To select candidate sites, we performed a unilateral brain injection with the AAV 
coding for the ChR2-mCherry construct and stained the brain sections with DAB (Figure 
12) to label mCherry with a black nickel stain. Since the virus coded for ChR2, which 
inserted itself in the cell membrane of the soma and axon, mCherry was expressed 
throughout the entirety of any cell that had been transfected. We examined these sections 
to determine which areas of the brain had dense projections of axons originating in the 
PPT.  
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Figure 12. DAB stain of PPTglut projections to terminal fields. A) Basal forebrain (-
0.1mm, relative to bregma). B) Lateral hypothalamus (-1.58 mm, relative to bregma). C) 
Thalamus (-1.06mm, relative to bregma). D) Substantia nigra (-3.08 mm, relative to 
bregma). Scale bar for first row = 1 mm. Scale bar for second row = 0.2 mm. 
  
Besides density of projections, the second criteria for selecting a target site was 
whether a region had previously been associated with the generation of wakefulness. 
There is evidence that the basal forebrain, lateral hypothalamus, and thalamus all to 
contribute to arousal from sleep. We chose the substantia nigra as our fourth candidate 
site because of its potential involvement in the motor phenotype that we observed during 
stimulation of the PPTglut cell bodies, and based on the knowledge that PPTglut neurons 
contact dopamine neurons in the substantia nigra, which are involved in locomotion 
(Charara et al., 1996; Clarke et al., 1987; Futami et al., 1995; Hägglund et al., 2010; Lee 
et al., 2014). The data on this motor phenotype is discussed later in this results section 
(Figure 17 and 18).  
Frequency-dependent wake response during NREM sleep 
Using the optogenetic techniques described for cell body stimulation, we 
selectively activated only the PPTglut axonal projections that innervate these terminal 
A)                                B)                                C)                                D) 
A)        B)   C)   D) 
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fields by placing our optical fibers in the basal forebrain, lateral hypothalamus, thalamus, 
and substantia nigra. All experimental manipulations and data analyses were performed 
for each terminal site as they were done for the PPTglut soma. 
During stimulation protocol 1, activation of terminals in the basal forebrain during 
NREM sleep revealed a frequency-dependent wake response (Figure 13A) similar to that 
found during soma stimulations. The mice woke up quickly after onset of stimulation, 
and the percent wakefulness was high with higher-frequency stimulations (5 Hz, 10 Hz, 
20 Hz). However, wakefulness fell quickly back to baseline after withdrawal of 
stimulation. Percent wakefulness remained at 76% 30 seconds after 20 Hz stimulation of 
the PPTglut soma, but was down to 40% at the same timepoint with photostimulation of 
PPTglut axons in the basal forebrain. Compared to stimulations at the PPTglut soma, 
stimulations of the axons in the basal forebrain did not produce a long-lasting wake 
response. 
 Stimulations at 20 Hz in the axon terminal field in the lateral hypothalamus of one 
mouse during NREM sleep kept the animal awake for a prolonged period of time after 
the end of stimulation (Figure 13A), which also occurred with PPTglut cell body 
stimulation (Figure 5), but not with stimulation of the basal forebrain axon terminals 
(Figure 13A). Lower stimulation frequencies (5 Hz, 10 Hz) produced a significant wake 
response, but did not keep the mouse awake after the end of stimulation.  
Stimulation of the thalamus terminal field during NREM sleep produced a 
relatively weak wake response (Figure 13C). Most stimulation frequencies did not have 
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a strong effect on wakefulness. Even the highest frequency tested (20 Hz) only increased 
wakefulness to a maximum of 62% (during the second epoch of stimulation). 
Stimulations of the substantia nigra terminal field showed a markedly different 
wake response compared to stimulations at the soma and other terminal fields. The wake 
response was delayed, reaching its maximum in the epoch after the stimulation ended 
(Figure 13D). Percent wakefulness returned to baseline levels quickly after the end of 
stimulation. Similar to what was observed with stimulation of other axon fields, lower 
frequencies (0.5 Hz-1 Hz) did not appear to wake the mice from NREM sleep. At 5 Hz, 
10 Hz, and 20 Hz stimulations, mice began to show a noticeable wake response compared 
to sham stimulation. 
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Figure 13. Frequency-dependent wake response to stimulation during NREM sleep 
at PPTglut axon terminals. A) Stimulation in the basal forebrain produced a frequency-
dependent wake response that occurred rapidly after stimulation onset, but returned to 
baseline quickly after end of stimulation. B) Stimulation in the lateral hypothalamus 
produced a frequency-dependent wake response. Percent wakefulness increased with 
stimulations at 5 Hz and above, but only 20 Hz produced prolonged wake. C) Stimulation 
in the thalamus produced a weak frequency-dependent wake response that was not 
prolonged after the end of stimulation. D) Stimulation in the substantia nigra produced a 
brief frequency-dependent wake response that did not persist after the end of stimulation. 
Grey bar represents the 10 s of 5 hz stimulation period. Data scored in 5 s epochs.  
 
Sleep architecture 
 
With stimulation of the basal forebrain terminal field of PPTglut neurons, sleep 
architecture (Figure 14A) maintained the same general trend as with PPTglut soma 
stimulations (Figure 7). However, the amplitude of the wake response was smaller. With 
soma stimulations, mice were awake 93% of the time during the epoch when stimulation 
occurred, while mice stimulated at axons in the basal forebrain were awake only 76% of 
the time during the 10-second stimulation. The sleep architecture of these mice reflects 
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the lack of strong wake response with 5 Hz stimulations in the basal forebrain (Figure 
13A).  
Stimulation of the lateral hypothalamus terminal field produced an effect similar to 
that of the mice stimulated at the PPTglut basal forebrain terminal field, with mice 
spending 79% of their time in a wake state during stimulation (Figure 14B).  
Stimulation of PPTglut axon terminals in the thalamus only slightly decreased the 
amount of time spent in NREM sleep and slightly increased the amount of time spent in 
wake (Figure 14C). Time spent in REM sleep was largely unaffected, similarly to 
stimulation of the PPTglut basal forebrain and lateral hypothalamus projections.  
With stimulation at the substantia nigra axon terminals, sleep architecture showed an 
effect similar to that observed at the PPTglut terminal fields in the basal forebrain and 
lateral hypothalamus (Figure 14D). During the first epoch of stimulation, the amount of 
time spent in wake increased to 68%, from a baseline around 40%. There was a 
corresponding decrease in time spent in NREM sleep, decreasing to 20% during 
stimulation, from a baseline level near 50%. Time spent in REM sleep was not affected 
by stimulation. 
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Figure 14. Sleep architecture with stimulation at the PPTglut axon terminals. A) 
Stimulation in the basal forebrain induced a decrease in time spent in NREM sleep, 
increase in time spent in wake, and no change in time spent in REM sleep. B) Stimulation 
in the lateral hypothalamus increased the time spent in wake, decreased time spent in 
NREM sleep, and did not change time spent in REM sleep. C) Sleep architecture was 
only weakly influenced by stimulation in the thalamus, resulting in a slight increase in 
time spent in wake, slight decrease in time spent in NREM sleep, and no change in time 
0
10
20
30
40
50
60
70
80
90
100
-60 -50 -40 -30 -20 -10 0 10 20 30 40 50 60
Pe
rc
en
t t
im
e 
in
 st
at
e
Time, relative to stimulation (s)
Thalamus (n = 1)
NREM REM Wake
0
10
20
30
40
50
60
70
80
90
100
-60 -50 -40 -30 -20 -10 0 10 20 30 40 50 60
Pe
rc
en
t t
im
e 
in
 st
at
e
Time, relative to stimulation (s)
Substantia Nigra (n = 2)
NREM REM Wake
C) 
D) 
 38 
 
spent in REM sleep. D) Stimulation in the substantia nigra resulted in a slight increase in 
time spent in wake, slight decrease in time spent in NREM sleep, and no change in time 
spent in REM sleep. 5 Hz stimulation. Grey bar represents the 10 s of 5 hz stimulation 
period. Data scored in 10 s epochs, taken from the first light period.  
 
NREM sleep bout length and latency to wake from NREM sleep 
5 Hz stimulation of the basal forebrain axons did not significantly change NREM 
sleep bout length (Figure 15A, p = 0.273) nor latency to wake (Figure 15B, p = 0.340) if 
the randomized stimulations occurred during NREM sleep. This result seems 
contradictory to the clear wake response previously described with stimulation of the 
PPTglut axons in the basal forebrain at varying frequencies. This discrepancy may be 
partially explained by the large standard error of the mean in the data for latency to wake 
(Figure 15B). 
Preliminary data suggests that stimulation of the glutamatergic projections from the 
PPT in the lateral hypothalamus lowers both NREM sleep bout length (Figure 15C) and 
latency to wake (Figure 15D) if the stimulation occurs during NREM sleep. 
With stimulations in the thalamus, the NREM sleep bout length slightly decreased 
(Figure 15E), while latency to wake after stimulation slightly increased (Figure 15F).  
Stimulation in the substantia nigra did not affect NREM sleep bout length (Figure 
15G), while latency to wake slightly decreased (Figure 15H).  
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Figure 15. Bout length and latency to wake with stimulation during NREM sleep at 
the PPTglut axon terminals. Optogenetic stimulation of the basal forebrain terminal field 
during NREM sleep did not significantly change A) NREM sleep bout length or B) 
latency to wake. n = 4 mice. Stimulation of the lateral hypothalamus projections 
decreased C) NREM sleep bout length and D) latency to wake. n = 1 mouse. Stimulation 
of thalamic projections slightly decreased E) NREM sleep bout length, and F) slightly 
increased latency to wake. n = 1 mouse. Stimulation of substantia nigra projections 
produced no change in G) NREM sleep bout length and a slight decrease in H) latency to 
wake. n = 1 mouse. 10 s stimulation at 5 Hz. Data taken from first 15 stimulations during 
the light period. 
 
REM bout length and latency to wake from REM sleep 
Stimulations at the basal forebrain terminal field did not significantly change 
REM sleep bout length (Figure 16A, p = 0.397) or latency to wake (Figure 16B, p = 
0.994) if the stimulation occurred during REM sleep. 
When stimulations of the lateral hypothalamus terminal field fell during REM sleep, 
our data shows that stimulation did not have a strong diminishing effect on REM sleep 
bout length (Figure 16C) or latency to wake (Figure 16D). Stimulation may, in fact, 
lengthen both REM sleep bout length and latency to wake.  
Stimulations of axon terminals in the thalamus of one mouse slightly increased both 
REM sleep bout length (Figure 16E) and latency to wake from stimulation (Figure 16F). 
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Both REM sleep bout length (Figure 16G) and latency to wake (Figure 16H) 
increased slightly with stimulation at the substantia nigra terminal field. 
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Figure 16. Bout length and latency to wake with stimulation during REM sleep at 
the PPTglut axon terminals. Optogenetic stimulation of the basal forebrain terminal field 
during REM sleep did not significantly change A) REM sleep bout length or B) latency 
to wake. n = 4 mice. Stimulation of lateral hypothalamus projections did not have a 
strong effect on C) REM sleep bout length or D) latency to wake. n = 1 mouse. 
Stimulation of thalamic projections was associated with a slight increase in E) REM 
sleep bout length and F) latency to wake. n = 1. Stimulation of substantia nigra terminal 
fields slightly increased G) REM sleep bout length and H) latency to wake. n = 1. 10 s 
stimulation at 5 Hz. Data taken from first 15 stimulations during the light period. 
 
Movement phenotype 
 Photostimulating mice during NREM sleep at the PPTglut soma revealed an abrupt 
change from NREM sleep to a wake-like EEG immediately upon onset of stimulation 
(Figure 17A), but mice did not move for the entirety of the 10-second stimulation. 
However, mice began moving immediately after the stimulation ended. We observed this 
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effect at frequencies of 5 Hz, 10 Hz, and 20 Hz for mice with stimulations at the PPTglut 
soma. Sample traces demonstrating this movement effect are included in Figure 17.  
We were curious which terminal projections of the PPTglut neurons could be 
contributing to this effect. None of the four candidate terminal fields produced a similar 
effect with 5 Hz stimulations, as mice stimulated at terminal fields in the basal forebrain, 
lateral hypothalamus and thalamus usually moved during 5 Hz stimulation (Figure 17B). 
However, when we stimulated the substantia nigra terminal field at 10 and 20 Hz, the 
mice did not move during stimulation (Figure 17C).  
 
  
Figure 17. Sample traces of EEG and EMG during stimulation. A) 5 Hz stimulation 
at the PPTglut soma. B) Stimulation at the PPTglut axonal fields in the basal forebrain. This 
trace is similar to the observed EEG and EMG activity with photostimulation in the 
lateral hypothalamus and thalamus. C) Stimulation of PPTglut axons in the substantia 
nigra. Blue bar represents 10 s stimulation. Black calibration bar is 5 s. 
 
B) 
C) 
A) 
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To investigate whether mice were unable to move during the stimulation period, 
we gently prodded them with a cotton swab during stimulation. Poking the mice 
prompted movement during stimulation at both the soma and all terminal fields of PPTglut 
axons. This suggests that the movement phenotype may be due to a lack of motivation to 
move, rather than a physical inability to move. 
We attempted to quantify this motor phenotype and recorded EEG/EMG signals 
and video for 24 hours with a 5-minute-long stimulation train at 5 Hz occurring every 30 
minutes. We measured the latency to the first significant movement after the onset of the 
stimulation. Mice took an average of 200 seconds to move with stimulation applied to the 
PPTglut soma. This data, displayed in Figure 18, corroborates our previous observations 
made using the 10 s stimulation protocol (Figure 17). So far, mice with stimulation of 
PPTglut axons did not show a significant delay of the latency to move, but the number of 
mice in each group is low, and this is still under investigation. 
 
Figure 18. Latency to move during 5-minute photostimulation of PPTglut soma and 
axon terminals. 5 min stimulation at 5 Hz. n = 5 mice for soma, n = 4 mice for basal 
forebrain, n = 1 mouse for lateral hypothalamus, n = 1 mouse for thalamus, n = 2 mice for 
substantia nigra. 
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Confocal microscopy 
 To assess local connections, we examined axonal projections of PPTglut neurons 
with fluorescent confocal microscopy. Based on our DAB-stained slides in Figure 12, it 
was clear that PPTglut neurons appose the four axonal terminal fields we chose to 
investigate. To investigate which neurons were contacted, we performed a series of 
fluorescent staining on tissue from vGluT2-cre mice previously injected with an AAV-
ChR2-mCherry in the PPT. We stained for ChAT in the basal forebrain, for MCH and 
orexin in the lateral hypothalamus, and for tyrosine hydroxylase in the substantia nigra. 
We then performed high-resolution confocal imaging in the relevant areas, which 
suggested that PPTglut neurons contacted cholinergic neurons in the basal forebrain, MCH 
and orexin neurons in the lateral hypothalamus, and dopamine neurons in the substantia 
nigra (Figure 19). 
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Figure 19: Fluorescent confocal images of PPTglut axon terminals. PPTglut axon 
terminals (red) contact cholinergic neurons (basal forebrain), MCH neurons (lateral 
hypothalamus), orexin neurons (lateral hypothalamus), and tyrosine hydroxylase neurons 
(substantia nigra).  
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DISCUSSION  
 We used optogenetics to activate neurons during specific sleep states and deliver 
targeted activation to axon terminals, to further characterize the wake-promoting 
properties of glutamatergic neurons in the PPT beyond what has already been revealed by 
chemogenetic techniques (Kroeger et al., 2017). We found a significant, frequency-
dependent wake response with photostimulation of the PPTglut soma during NREM sleep, 
and a slight reduction in REM sleep with photostimulation. Photostimulation at the 
PPTglut soma also induced a lack of spontaneous movement in mice. These effects were 
mediated to varying extents by PPTglut projections to the basal forebrain, lateral 
hypothalamus, thalamus, and substantia nigra.  
Responses to photostimulation of PPTglut soma during NREM differ from responses 
during REM 
 Stimulating PPTglut soma while mice were in NREM sleep produced a frequency-
dependent wake response, where higher frequencies of stimulation increased the rapidity 
of the wake response as well as the the amplitude and duration of wake. This was coupled 
with a corresponding decrease in EEG delta power, shifting away from delta power 
values characteristic of NREM sleep and towards values characteristic of wake. These 
data support the notion of a population of PPTglut neurons ‘wake-promoting’ cells, as was 
previously shown with wake responses to NMDA receptor activation in the PPT (Datta et 
al., 2001).  
 Moreover, we showed that activation of the PPTglut soma reduced time spent in 
NREM sleep, increased time spent in wake, and slightly decreased REM sleep. Prior 
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studies of the discharge profiles of PPT cells have found populations of PPTglut cells that 
fire maximally during both wake and REM (Boucetta et al., 2014). Our findings agree 
with the characterization of PPTglut neurons as wake-promoting, but suggest that 
photostimulation of PPTglut neurons may decrease REM sleep. 
Varying contributions from PPTglut axon terminal fields 
 We examined through which PPTglut axon terminal fields the wake response might 
be produced. The target areas were chosen based on their known roles in the generation 
of wakefulness (basal forebrain, lateral hypothalamus, thalamus), and movement 
(substantia nigra). Confocal images showed appositions of PPTglut axon terminals on 
cholinergic neurons in the basal forebrain, orexin and MCH neurons in the lateral 
hypothalamus, and dopaminergic neurons in the substantia nigra.  
The phenotype of the wake response from NREM sleep observed after stimulation 
of PPTglut soma appeared to be a summation of the phenotypes obtained by stimulating 
the different axonal fields, with each field contributing a slightly different aspect of the 
phenotype. Stimulation at PPTglut axon terminals in the basal forebrain, lateral 
hypothalamus, and thalamus elicited a fast wake response from NREM sleep. A high-
amplitude waking response was seen with basal forebrain and lateral hypothalamus 
terminal field stimulation, and a long-lasting wake response was seen only with high 
frequency stimulation of axons in the lateral hypothalamus. REM sleep was generally 
unaffected by activation of any of these terminal fields.  
These wake-promoting effects from NREM sleep, but not REM sleep are 
similarly demonstrated by optogenetic studies of the lateral hypothalamus projections to 
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the thalamus (Herrera et al., 2016), as well as chemogenetic studies of the lateral 
hypothalamus-ventrolateral preoptic nucleus circuit (Venner et al., 2016). Activation of a 
reward pathway may contribute to the wake response, as PPTglut neurons project to 
dopaminergic neurons in the ventral tegmental area and create a reinforcing effect (Yoo 
et al., 2017). 
Lack of movement during photostimulation of PPTglut soma  
We also noted that during stimulation of PPTglut soma at frequencies higher than 5 
Hz, mice did not exhibit spontaneous body movements. Movement could, however, be 
evoked with a stimulus, such as a physical prod. At a histological level, strong 
projections were apparent from the PPTglut to the substantia nigra, which gates motor 
movement.  
We used 5-minute-long stimulations to quantify this phenomenon and found that 
mice stimulated at the PPTglut soma took, on average, 140 seconds to move. This lack of 
movement stands in contrast to some literature on the mesencephalic motor region 
(MLR), an area of the brain which is defined functionally as part of the ascending 
reticular activating system, and anatomically as the PPTglut (Lee et al., 2014). In prior 
experiments, stimulation of the MLR produced locomotion, while lesions caused 
immobility (Sherman et al., 2015). Optogenetic stimulation of the entire MLR also 
produced locomotion in a separate experiment (Lee et al., 2014). However, another study 
suggested that MLR glutamatergic neurons are necessary and sufficient for locomotion 
(Roseberry et al., 2016). The lack of spontaneous movement during stimulation of PPTglut 
soma requires further investigation. 
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Stimulating PPTglut axon terminals in the basal forebrain, lateral hypothalamus, 
and thalamus did not produce the motor inhibition phenotype observed with PPTglut soma 
stimulation. Stimulation at axon terminals in the substantia nigra produced wake 
responses, and delayed spontaneous movement only during high-frequency stimulation.  
Limitations 
 With microinjections, we run the risk of transfecting cells in nearby regions. The 
periaqueductal grey, which is involved in fear, lies medial to the PPT. The parabrachial 
nucleus is also in close proximity to the PPT, and glutamatergic signals from this nucleus 
contribute to an arousal pathway (Kaur et al., 2013). Microinjections into deep brain 
structures are a challenging task, and viral transfection of glutamatergic neurons was not 
always 100% within the confines of the PPT. These off-target injections were likely due 
to variability beteween neuroanatomy of mice, as our stereotaxic instruments are precies 
to one micron. We will mediate this potential issue by replicating each experimental  
protocol using at least 6 mice with successful injections. 
Future directions 
This project is ongoing, and will likely not be complete until Summer 2018. For 
this reason, our cohort numbers were low for most of the PPTglut terminal field mice. 
Data presented for stimulation of the lateral hypothalamus (n = 1) and thalamus (n = 1) 
should be considered preliminary until the results have been reproduced with more mice. 
The cohort number will be raised to at least 6 for all mice stimulated at the PPTglut axon 
terminal fields. 
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We will analyze unilateral vs. bilateral stimulation data in all of the PPTglut axonal 
terminal fields, as was done for PPTglut cell body stimulations. Additionally, we intend to 
probe the motor inhibition phenotype with conditions that match those in which the 
phenomenon was first observed.  
Conclusion 
Photostimulation of PPTglut neurons is incompatible with NREM sleep, but not 
entirely incompatible with REM sleep. We have examined one region of the brainstem 
‘reticular formation’ and found wake-promoting effects of glutamatergic PPT neurons. 
These wake-inducing effects during NREM sleep are mediated, at least partially, by 
PPTglut axonal projections to the basal forebrain, an area known to be associated with 
wakefulness. Future studies of PPTglut neurons might investigate during which wake 
behaviors they are specifically active in, and further examine the lack of spontaneous 
movement induced by PPTglut photostimulation. 
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